Total Payments
$4,207
2024 Payments
$1,588
Companies
38
Transactions
107
Medicare Patients
693
Medicare Billing
$156,519
Payment Breakdown by Category
Food & Beverage$2,334 (55.5%)
Consulting$1,575 (37.4%)
Education$297.99 (7.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,334 | 101 | 55.5% |
| Consulting Fee | $1,575 | 3 | 37.4% |
| Education | $297.99 | 3 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,672 | 8 | $0 (2024) |
| Amgen Inc. | $334.03 | 7 | $0 (2023) |
| Janssen Biotech, Inc. | $203.82 | 7 | $0 (2021) |
| Genentech USA, Inc. | $169.65 | 7 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $162.00 | 8 | $0 (2023) |
| PFIZER INC. | $158.77 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $154.64 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $145.59 | 9 | $0 (2023) |
| Incyte Corporation | $115.00 | 1 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $99.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,588 | 4 | AstraZeneca Pharmaceuticals LP ($1,575) |
| 2023 | $863.68 | 48 | Novartis Pharmaceuticals Corporation ($72.97) |
| 2022 | $361.85 | 20 | Genentech USA, Inc. ($46.70) |
| 2021 | $541.46 | 25 | Janssen Biotech, Inc. ($203.82) |
| 2020 | $18.33 | 1 | AstraZeneca Pharmaceuticals LP ($18.33) |
| 2018 | $313.99 | 3 | Incyte Corporation ($115.00) |
| 2017 | $519.26 | 6 | Amgen Inc. ($125.00) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | Truqap (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 05/06/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $13.36 | General |
| Category: Hematology | ||||||
| 12/18/2023 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), KISQALI | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Oncology | ||||||
| 12/05/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Oncology | ||||||
| 11/06/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $16.74 | General |
| Category: Oncology | ||||||
| 10/31/2023 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: BioOncology | ||||||
| 10/25/2023 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $13.78 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 10/24/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: Oncology | ||||||
| 10/17/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: Oncology | ||||||
| 10/16/2023 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug), IDHIFA | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Oncology | ||||||
| 10/11/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: HORMONE THERAPY | ||||||
| 10/04/2023 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: CELLT | ||||||
| 10/04/2023 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Oncology | ||||||
| 09/26/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Oncology | ||||||
| 09/12/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $37.59 | General |
| Category: Oncology | ||||||
| 08/23/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Oncology | ||||||
| 08/22/2023 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), KISQALI | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Oncology | ||||||
| 08/21/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $13.00 | General |
| Category: Hematology | ||||||
| 08/07/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), JEMPERLI, ZEJULA | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: VACCINES | ||||||
| 07/25/2023 | PFIZER INC. | BOSULIF (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 07/24/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Oncology | ||||||
| 07/12/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 142 | 370 | $84,701 | $43,652 |
| 2022 | 7 | 209 | 364 | $88,847 | $37,940 |
| 2021 | 8 | 214 | 460 | $123,195 | $59,482 |
| 2020 | 6 | 128 | 165 | $39,073 | $15,445 |
Total Patients
693
Total Services
1,359
Medicare Billing
$156,519
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 172 | $42,272 | $22,694 | 53.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 150 | $27,249 | $13,994 | 51.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $8,430 | $3,978 | 47.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $6,750 | $2,986 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 175 | $42,228 | $17,052 | 40.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 61 | $16,476 | $8,454 | 51.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $8,670 | $3,926 | 45.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 31 | $6,997 | $2,755 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 36 | $6,166 | $2,403 | 39.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $3,890 | $1,862 | 47.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 19 | 20 | $4,420 | $1,488 | 33.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 42 | 172 | $45,834 | $26,686 | 58.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 170 | $42,840 | $18,668 | 43.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $9,300 | $4,291 | 46.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 22 | 24 | $10,584 | $4,192 | 39.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 19 | $4,389 | $1,714 | 39.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 16 | 16 | $4,704 | $1,688 | 35.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $2,820 | $1,192 | 42.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 16 | $2,724 | $1,051 | 38.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 32 | 54 | $13,608 | $4,926 | 36.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 27 | 30 | $8,820 | $3,470 | 39.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 23 | 23 | $6,900 | $3,191 | 46.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 14 | 14 | $6,174 | $2,452 | 39.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 21 | $3,318 | $1,311 | 39.5% |
| 96127 | Brief emotional or behavioral assessment | Office | 2020 | 20 | 23 | $253.00 | $94.50 | 37.4% |
About Dr. John Savooji, MD
Dr. John Savooji, MD is a Hematology & Oncology healthcare provider based in Jefferson City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2013. The National Provider Identifier (NPI) number assigned to this provider is 1447684808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Savooji, MD has received a total of $4,207 in payments from pharmaceutical and medical device companies, with $1,588 received in 2024. These payments were reported across 107 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($2,334).
As a Medicare-enrolled provider, Savooji has provided services to 693 Medicare beneficiaries, totaling 1,359 services with total Medicare billing of $156,519. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Jefferson City, MO
- Active Since 08/21/2013
- Last Updated 05/02/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1447684808
Products in Payments
- IMFINZI (Biological) $585.93
- LYNPARZA (Drug) $525.00
- Truqap (Drug) $525.00
- IMBRUVICA (Drug) $203.15
- OPDIVO (Biological) $154.64
- KEYTRUDA (Biological) $133.61
- IBRANCE (Drug) $129.72
- Neulasta (Biological) $125.00
- JAKAFI (Drug) $115.00
- JEVTANA (Drug) $99.00
- CYRAMZA (Drug) $89.60
- REBLOZYL (Biological) $69.06
- DARZALEX (Biological) $59.33
- KISQALI (Drug) $58.18
- VENCLEXTA (Biological) $51.38
- LUMAKRAS (Drug) $49.00
- XPOVIO (Drug) $45.91
- Lunsumio (Biological) $41.57
- INJECTAFER (Drug) $39.64
- Nubeqa (Drug) $37.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Jefferson City
Shadi Haddadin, Md, MD
Hematology & Oncology — Payments: $50,117
Hematology & Oncology $50,117
Dr. Ali Khojasteh, M.d, M.D
Hematology & Oncology — Payments: $27,148
Hematology & Oncology $27,148
Dr. Tamara Hopkins, M.d, M.D
Hematology & Oncology — Payments: $7,839
Hematology & Oncology $7,839
Rolando Breier, Md, MD
Hematology & Oncology — Payments: $4,208
Hematology & Oncology $4,208
Joseph Doggett, D.o, D.O
Hematology & Oncology — Payments: $30.59
Hematology & Oncology $30.59